Cargando…
Propranolol eye drops in patients with corneal neovascularization
RATIONALE: Studies performed in animal models of corneal neovascularization suggested the possible efficacy of a treatment with propranolol. Corneal neovascularization is one of the most feared complications of Stevens–Johnson syndrome that frequently involves ocular surface. We report the first 2 p...
Autores principales: | Filippi, Luca, de Libero, Cinzia, Zamma Gallarati, Barbara, Fortunato, Pina, Piozzi, Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6250516/ https://www.ncbi.nlm.nih.gov/pubmed/30407290 http://dx.doi.org/10.1097/MD.0000000000013002 |
Ejemplares similares
-
Infliximab eye drops treatment in corneal neovascularization
por: Voiculescu, OB, et al.
Publicado: (2015) -
Propranolol 0.2% Eye Micro-Drops for Retinopathy of Prematurity: A Prospective Phase IIB Study
por: Filippi, Luca, et al.
Publicado: (2019) -
The inhibitory effect of different concentrations of KH902 eye drops on corneal neovascularization induced by alkali burn
por: Wu, Yan, et al.
Publicado: (2017) -
Study protocol: safety and efficacy of propranolol 0.2% eye drops in newborns with a precocious stage of retinopathy of prematurity (DROP-ROP-0.2%): a multicenter, open-label, single arm, phase II trial
por: Filippi, Luca, et al.
Publicado: (2017) -
Corneal Penetration of Low-Dose Atropine Eye Drops
por: Austermann, Henning, et al.
Publicado: (2021)